Federal appeals court reinstates corporate ownership over human genes for breast cancer
Reversing a previous decision by a US District Court that declared gene patenting to be invalid, the US Court of Appeals for the Federal Circuit (CAFC) recently ruled in opposition, declaring that certain gene variants are supposedly unnatural and can thus be legally